Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels.
Lee KA, Hammerle LP, Andrews PS, Stokes MP, Mustelin T, Silva JC, Black RA, Doedens JR.
J Biol Chem. 2011 Dec 2;286(48):41530-8. Epub 2011 Oct 10.
Related citations
NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.
Mori T, Ikeda DD, Fukushima T, Takenoshita S, Kochi H.
Cell Cycle. 2011 Oct 1;10(19):3284-99. Epub 2011 Oct 1.
Phosphorylation-dependent regulation of SCF(Fbx4) dimerization and activity involves a novel component, 14-3-3ɛ.
Barbash O, Lee EK, Diehl JA.
Oncogene. 2011 Apr 28;30(17):1995-2002. Epub 2011 Jan 17.
Suppression of cancer cell growth by promoting cyclin D1 degradation.
Shan J, Zhao W, Gu W.
Mol Cell. 2009 Nov 13;36(3):469-76.
Biochemical analysis of the Anaphase Promoting Complex: activities of E2 enzymes and substrate competitive (pseudosubstrate) inhibitors.
Summers MK, Jackson PK.
Methods Mol Biol. 2009;545:313-30.
F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage.
Santra MK, Wajapeyee N, Green MR.
Nature. 2009 Jun 4;459(7247):722-5. Epub 2009 May 3.
A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.
Okabe H, Lee SH, Phuchareon J, Albertson DG, McCormick F, Tetsu O.
PLoS One. 2006 Dec 27;1:e128.
Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286.
Germain D, Russell A, Thompson A, Hendley J.
J Biol Chem. 2000 Apr 21;275(16):12074-9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on